Asli Bolayir

Asli Bolayir

Auto-generated profile, based on publicly available information

Asli Bolayir

Sivas Cumhuriyet Univ, Dept Neurol, Fac Med, Sivas, Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Closed access
ABAsli Bolayir
Asli Bolayir
SGSeyda Figul Gokce
Seyda Figul Gokce
BCBurhanettin Cigdem
Burhanettin Cigdem
HBHasan Ata Bolayir
Hasan Ata Bolayir
OYOzlem Kayim Yildiz
Ozlem Kayim Yildiz
STSuat Ahmet Topaktas
Suat Ahmet Topaktas
The inflammatory process is a very important stage in the development and prognosis of acute ischemic stroke (AIS). The monocyte to high-density lipoprotein (HDL) ratio (MHR) is accepted as a novel marker for demonstrating inflammation. However, the role of MHR as a predictor of mortality in patients with AIS remains unclear. We retrospectively enrolled 466 patients who were referred to our clinic within the first 24hours of symptom presentation and who were diagnosed with AIS between January 2008 and June 2016. Four hundred and eight controls of similar age and gender were also included. The patient group was classified into two groups according to 30-day mortality. The groups were compared in terms of monocyte counts, HDL, and MHR values. The patient group had significantly higher monocyte counts and lower HDL levels; therefore, this group had higher values of MHR compared to controls. Additionally, the monocyte count and MHR value were higher, and the HDL level was lower in non-surviving patients (p<0.001). The MHR value was also observed as a significant independent variable of 30-day mortality in patients with AIS (p<0.001). The optimum cut-off value of MHR in predicting the 30-day mortality for patients with AIS was 17.52 (95% CI 0.95-0.98). Our study demonstrated that a high MHR value is an independent predictor of 30-day mortality in patients with AIS.

1 October 2017 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
ABAsli Bolayir
Asli Bolayir
BCBurhanettin Cigdem
Burhanettin Cigdem
SGSeyda Figul Gokce
Seyda Figul Gokce
HBHasan Ata Bolayir
Hasan Ata Bolayir
OYOzlem Kayim Yildiz
Ozlem Kayim Yildiz
STSuat Ahmet Topaktas
Suat Ahmet Topaktas

11 February 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
ŞGŞeyda Figül Gökçe
Şeyda Figül Gökçe
BÇBurhanettin Çi̇ğDem
Burhanettin Çi̇ğDem
SKSanem Nemmezi̇ Karaca
Sanem Nemmezi̇ Karaca
ABAslı BOLAYIR
Aslı BOLAYIR
ÖYÖzlem Kayim Yildiz
Özlem Kayim Yildiz
ATAhmet Suat Topaktaş
Ahmet Suat Topaktaş
Multiple sclerosis (MS) is a common neurological disorder that can be a leading cause of nontraumatic disability in several countries. Recent reports have indicated a moderate to high risk of MS in European countries. In this study, we examined the prevalence of MS in a well-defined urban population of provincial center in Sivas Province in Turkey. This study sampled all registered residents of urban areas of provincial center in Sivas Province in April 2017 and 2018 January. All the included patients met the McDonald 2010 criteria. Medical records were reviewed, including all available previously acquired magnetic resonance imaging data. All patients were subsequently subjected to neurologic examination to confirm the MS diagnosis. We identified 21 possible MS patients, with MS diagnosis confirmed in 19. The prevalence of MS was 288 per 100,000 inhabitants. For future studies, these high ratio results can be used in regional and national comparisons to determine cofactors contributing to the high prevalence of MS in our region and can help health-decision makers to better plan healthcare policies to improve neurological services and awareness about multifaceted clinical presentations of MS.

1 May 2018 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
HBHasan Ata Bolayır
Hasan Ata Bolayır
TKTarık Kıvrak
Tarık Kıvrak
HGHAKAN GUNES
HAKAN GUNES
DADursun Akaslan
Dursun Akaslan
ÖŞÖmer Şahin
Ömer Şahin
ABAslı Bolayır
Aslı Bolayır
There is an important link between platelets and inflammation, thrombosis, and vascular and tissue repair mechanisms. SCUBE1 (signal peptide-CUB-EGF domain-containing protein 1) may function as a novel platelet-endothelial adhesion molecule and play pathological roles in cardiovascular biology. Stent thrombosis (ST) following percutaneous coronary intervention is an uncommon and potentially catastrophic event that can manifest as myocardial infarction and sudden death. High platelet reactivity is a risk factor for thrombotic events, including late ST. For this reason, in the current study, we researched the role of SCUBE1 in the development of late coronary ST. We included 40 patients admitted to our hospital with a diagnosis of ST-elevation myocardial infarction (STEMI) and signs of late ST on a coronary angiogram. For the control group, we recruited 50 healthy gender- and age-matched individuals who were seen for health check-ups. We also randomly included 100 patients with a diagnosis of STEMI without ST. There were no significant differences between the groups in terms of baseline and demographic characteristics. The mean SCUBE1 level in patients with STEMI with late ST at admission and the STEMI without ST group was significantly higher than in the control group (p<0.01). The mean SCUBE1 level in the STEMI with late ST group was significantly higher than in the STEMI without ST group (p=0.03). In multivariate regression analysis, serum SCUBE1 (odds ratio [OR]: 1.022; 95% confidence interval [CI]: 1.011-1.033, p<0.001) remained an independent predictor for the presence of late ST. In addition, receiver operating characteristic curve analysis was used to determine the optimal SCUBE1 cut-off value for predicting late ST. The area under the curve was 0.972 (95% CI 0.95-0.98). The SCUBE1 cut-off value was 59.2 ng/ml, with a sensitivity of 95.4% and specificity of 82.9%. The present work is the first clinical study to demonstrate that serum SCUBE1 levels are significantly higher in patients with late ST and serum SCUBE1 was an independent predictor for the presence of late ST in our study population.

1 January 2021 in Bratislava Medical Journal
Verified
Journal Article
Closed access
ABA. Bolayir
A. Bolayir
BCB. Cigdem
B. Cigdem
SGS. F. Gokce
S. F. Gokce
DYD. Yilmaz
D. Yilmaz
The relationship between neutrophil/lymphocyte ratio and uric acid levels in multiple sclerosis patients

18 December 2017 in Cumhuriyet Medical Journal
Verified
Journal Article
Closed access
PDF file
ABAslı Bolayır
Aslı Bolayır
ŞGŞeyda Figül Gökçe
Şeyda Figül Gökçe
Amaç: Ortalama platelet hacmi (OPH) ve platelet dağılım genişliği (PDG), platelet hacmini gösteren parametrelerdir. Büyük plateletlerin küçük plateletlere kıyasla enzimatik ve metabolik olarak daha aktif kabul edilmektedir. Artmış OPH ve PDG değerleri ile arteryel tromboz arasındaki ilişki gösterilmiştir ancak venöz trombozdaki yeri tam olarak bilinmemektedir. İnflamatuar bir gösterge kabul edilen platelet/ lenfosit oranının artışının(PLO) birçok hastalıkla ilişkisi bilinmekteyken venöz trombozda kullanımı ile ilgili az sayıda çalışma mevcuttur. Bu nedenle bu çalışmamızdaki amacımız OPH, PDG ve PLO değerleri ile serebral venöz sinüs trombozu(SVST) arasındaki ilişkiyi ortaya koymaktır. Yöntem: Çalışmamıza retrospektif olarak Ocak 2008- Eylül 2016 tarihleri arasında kliniğimizde SVST tanısı ile izlenmiş 54 hasta ile benzer yaş ve cinsiyete sahip 50 kontrol dahil edildi. Hasta ve kontrol grubu OPH, PDG ve PLO değerleri açısından kıyaslandı. Bunun yanında hasta grubu kendi içinde beyin parankimal lezyonu olan ve olmayanlar olarak ikiye ayrılarak OPH, PDG ve PLO’nun prognoz üzerindeki etkisi de değerlendirildi. Bulgular: Hasta grubunda kontrollere kıyasla OPH, PDG ve PLO değerleri daha yüksekken parankimal lezyonu olan ve olmayan hastalar arasında anlamlı fark saptanmadı. Ek olarak SVST gelişimi için OPH ve PDG değerleri anlamlı bağımsız değişkenler olarak saptanırken ROC analizi ile optimum cut-off değerleri OPH için 8.85 iken, PDG için 15.75, PLO için ise 168.53 olarak tespit edildi. Sonuç: Sonuç olarak, OPH, PDG ve PLO değerleri SVST’li hastalarda kontrollerden daha yüksek bulunmuştur ancak prognozu belirlemede etkileri saptanmamıştır. Ek olarak, OPH ile PDG yüksekliğinin SVST gelişimi için yeni bir bağımsız risk faktörleri olduğunu söyleyebiliriz.